key: cord-1052201-zoabi8rx
authors: Diaz, Hernando; España, Guido; Castañeda, Nelson; Rodriguez, Laura; de la Hoz-Restrepo, Fernando
title: Dynamical characteristics of Covid-19 epidemic: Estimation from Colombia’s case
date: 2021-01-30
journal: Int J Infect Dis
DOI: 10.1016/j.ijid.2021.01.053
sha: d66d73e6aa9d159b50aee03bcee4ebb1575a4e61
doc_id: 1052201
cord_uid: zoabi8rx

Objectives To characterize the dynamics of the epidemic, for modeling purposes. Methods Data from Colombian official case information were collated for a period of five months. Dynamical parameters of the disease spread were then estimated from the data. Probability distribution models were identified that represent the time from symptom onset to hospitalization, to ICU admission and to death. Kaplan Meier estimates were also computed for the probability of eventually requiring hospitalization, needing ICU attention and of dying from the disease (the CFR). Results Probability distributions of the times and probabilities were computed for the population and for groups based on age and sex. Our results show that for the times that characterize the course of the disease for a given patient (to hospitalization, to ICU or death), the variation from an age group to another is very small (around of 10% of fixed effect intercept) and the effect of sex is even weaker (around 1%). The course of the disease appears to be very similar for all patients. The probability that a patient advances from one stage of the disease to another (to hospitalization, to ICU, to death), on the other hand, is heavily influenced by sex and age. Relative risk of death for males (based on 22924 dead) is 1.7. Conclusions The times from one stage of the disease to another are almost independent of the major patient’s variables (sex, age). This is in stark contrast to the probabilities of going from one stage to another which show a strong dependence on age and sex. Data also show that the length of hospital and ICU stays are almost independent of sex and age. The only factor that affects this length was the eventual outcome (survival or death) of the disease. The time is significantly longer for surviving patients.

After the first SARS-CoV-2 outbreak in Wuhan starting in December 2019, the COVID-19 epidemic reached Europe early in 2020. The first cases in Colombia were imported from Europe, according to the genetic information obtained for these first cases. The virus genetic sequences available to this date in Colombia show that most cases in the country come from Europe and the United States. The first officially reported case appeared on March 6th, imported from Italy and the first COVID-19 death occurred on de Salud Colombia, 2020). Starting in March 24th, a strict country level lockdown was ordered in Colombia that became gradually relaxed, due to the economic and social burden on citizens, notably in the low income sectors. As a result, the number of cases has grown steadily with more than 300 deaths each day by August 3rd (INS: Instituto Nacional de Salud Colombia, 2020). By mid-September the daily number of new cases and deaths started to decrease. In some cities, notably in the Amazon and Putumayo regions, with very scarce ICU capacity, some patients had to be translated to other cities, mostly to Bogota, as the number of severe cases overran the available Intensive Care Units (ICU) beds. Most of the exceeding cases still got critical clinical care at neighboring cities. The pandemic continues, however, and new peaks have occurred and are expected beyond the study horizon. On this date, the peak of the epidemic has just passed and both deaths and new cases have been descending for about a week, after a sustained plateau that lasted almost a month.

Several models have been proposed around the world to explain the local and global dynamics of the COVID-19 pandemic (Flaxman et al., 2020; Ray et al., 2020; Salje et al., 2020) . These models rely on publicly available data to continuously update their projections (Ray et al., 2020) . Parameters that describe the natural history of the disease have been estimated elsewhere, from many sources (Davies et al., 2020;  J o u r n a l P r e -p r o o f Fateh-Moghadam et al., 2020; Heald-Sargent et al., 2020; Hu et al., 2020; Wu et al., 2020) . These parameters are necessary to project the impact of the pandemic on local health systems (IHME COVID-19 health service utilization forecasting Team and Murray, 2020). The proportion of people infected who will develop symptoms for each age group has been estimated in Wuhan and other places (Wu et al., 2020) . The duration of hospitalization is estimated to be around 7-14 days in China (Hu et al., 2020) . In this paper, we used random variable models to represent the distribution of time from symptom onset to death, to hospital and ICU admission and the probability of a registered patient ultimately requiring hospitalization, ICU care or dying (the Case Fatality Ratio CFR) are estimated from official, publicly available, data.

One key parameter for the control of an epidemic, the Case Fatality Ratio (CFR), constitutes an upper bound for the Infection Fatality Rate (IFR) that quantifies the lethality of the disease. Estimation of the CFR is required to model the dynamics: this parameter is, approximately, the probability of one registered patient dying. The estimates need to consider the existence of active cases whose outcome is not yet decided (censoring). We used a commonly applied technique, the Kaplan-Meier method. This method or variants thereof have been utilized already for estimating CFR at several locations. For modelling purposes and also for public health policy planning, the probability of a given person eventually needing hospitalization and the probability of a hospitalized patient requiring ICU attention are important parameters. Their estimation is subject to the same uncertainty and nuances as the CFR. All three are modelled here as a survival process.

The objective of this analysis is to provide detailed models for the main variables that characterize the course of the disease in a Covid-19 patient. These include the duration of the main stages of the disease and the probability of progressing from one stage to the other: symptomatic to hospitalized; hospitalized to in ICU, from infected to dying. These are required for all detailed simulation models of the pandemic.

To the best of our knowledge, the dynamics of the process leading from infection to hospital, ICU admission and death have not been described in detail elsewhere.

J o u r n a l P r e -p r o o f

The only materials used in this study are publicly available official data from the Colombian government.

All data were obtained from the official COVID-19 epidemic data published daily by the Colombian Ministry of Health. That includes a record for each person identified as infected with SARS-CoV-2 (INS: Instituto Nacional de Salud Colombia, 2020). Each case has a number to identify it and serves to follow up that person's evolution. The records published include the date of symptom onset (TSO) for most patients as well as the date of report, date of death, when applicable, and date of recovery. According to the metadata, the date of recovery is sometimes determined by tests but, more often, it is inferred from time since TOS. Other information, updated daily, includes the state of the patient on that date and whether it is symptomatic or not.

Information on the current health state of the patients, dates of admission to a hospital and to ICUs are recorded. From this information, all the time intervals and fractions can be determined. Since all information is recorded once a day, the minimum time resolution is one day. Thus, all measured intervals are integer-valued.

Daily case information was collected manually from the official site of the Colombian National Institute of Health for the period from April 3rd 2020 to date (August 25th, 2020), with a few data points missing, corresponding to dates where connection was not possible or file was downloaded with errors. Currently, daily case information can be obtained from the Colombian government's open-data site (Covid-Colombia, 2020) . From these data, accumulated over time, approximate patients' histories were recorded. Daily case information was then collated to reconstruct each patient's history.

The information for each case includes the patient's age, sex and, for members of indigenous peoples, the ethnic group to which they belong. The date of symptom onset, diagnostic and death are also available, where appropriate. The age was converted to a discrete scale using the following brackets: {0-19,20-29,30-39,40-49,50-59,60-69,70-79,80+}. J o u r n a l P r e -p r o o f

The first bracket includes all patients younger than 20 years old. An interval that is wider than the other groups was chosen because the number of cases in this group is smaller than in other age groups and, for some analyses, they were too few to permit proper estimation.

The first step of data treatment was to compute descriptive statistics of the characteristic times and fractions of the population. Next, stochastic models were obtained to model the probability distribution of those characteristics.

From daily information on patient's conditions, the dates when the patient's health status changed were recorded. Then, using the sequence of state changes, the duration of each state was computed. Patients without a valid date of symptom onset were excluded from all analyses where this information was required (all except the probability of death, where the date of report, for asymptomatic patients, was used as the beginning of exposure). Similarly, for the computation of the time spent in the hospital and in ICU, only the patients who have left the hospital or ICU, respectively, were considered. The intervals from TSO to hospital, to ICU admission and to death were registered as the difference between the first date when the patient's state was registered as "In hospital" or "In ICU" and the symptom onset date, when applicable.

All analyses were done using the R programming and statistical software (R Core Team, 2020). Stochastic models were developed using Bayesian statistics with the brms package (Bürkner, 2018) . brms is based on Stan, an open source statistical modelling system.

In identifying adequate probability distributions to approximate characteristics of the epidemic in Colombia, several prospective random process candidates were tried.

For lengths of time, from TOS to hospital or from TSO to death, lognormal, Weibull and Gamma continuous distributions and a zero inflated negative binomial discrete distribution were tried. The estimates were then compared, using two different validation J o u r n a l P r e -p r o o f methods: WAIC (Widely Used Information Criterion) and the LOO (Leave One Out cross Validation); see McElreath, 2020 and Vehtari, 2017 . In all cases to be discussed here, both criteria favored the model that we eventually selected. For estimating probabilities or fractions, a survival model was applied, using the Kaplan Meier technique, based on the distribution of the times until event occurred (Bogaerts et al., 2017; Verity et al., 2020) . This is based on the hazard function ℎ( ), which may be computed from the distribution of time from symptom onset to the event. Since we found good approximations to the various times involved, they can then be used to compute the probabilities. For estimating survival probabilities, the R Survival package (Terry M. Therneau and Patricia M. Grambsch, 2000) was used.

The time from symptom onset to death was computed for all dead patients having symptom onset information. This parameter is required for simulating the epidemic dynamics, especially for CFR and IFR estimation. Estimating this time during the early phases of the epidemic may require careful consideration of biases introduced by censoring due to errors in onset registration or lack of onset information (Verity et al., 2020) . In our case, Of the 22,924 dead, TSO is known for 22,095 patients which is high enough so that a model was fitted to the data without further consideration. As reference for estimating case fatality ratios, it is noted that in this data set, 90% of all deaths occurred between 3 and 35 days from TSO and 829 (3.6%) deaths occurred in patients sheltering at home (did not receive hospital care). The distribution of times to death does not show any difference by sex (see supplementary information, from now on referred to as Supp.). Figure 1 shows The average time from onset to death was found for the age groups. This time can be accurately modeled by a Gamma distribution, with varying intercepts for different age groups, as presented in the supplementary information.

The length of time from symptom onset to hospital admission was recorded for = 50,667 patients nationwide, out of 619750 cases. The corresponding data for 7521 J o u r n a l P r e -p r o o f patients admitted to ICU were also recorded. From this information, probability distributions were found to accurately represent the distribution of the time between the onset of symptoms and hospitalization ( ) and from symptom onset to admission to ICU ( ).

The mean time to hospitalization, estimated from the data is 14.27 days with a median of 13 days. There are no significant differences between sexes or age groups, concerning the time to hospitalization.

J o u r n a l P r e -p r o o f ∼ Figure 2 . Probability density of time from symptom onset to hospitalization. By age. Details are available in the supplementary information.

The length of hospital ( = 11191) and ICU ( 

The computation of the Case Fatality Ratio (CFR), i.e. the fraction of cases leading to death, requires consideration of the censored data due to currently infected patients that may die in the future. Figure 4 shows the estimates for all age groups. The overall CFR (3.83%) may be compared to results for various countries, published by (Sudharsanan et al., 2020) . They provide estimates, ranging from high values for Italy (9.3%), Netherlands (7.4%), Spain (6.0%) to low in South Korea (1.6%) and

Germany ( 

For modeling purposes it is necessary to have an estimate of the probability of hospitalization for registered patients. This probability has been estimated as a survival process where surviving individuals are those who never require hospitalization. This avoids underestimating the hospitalizations due to cases that are still active and might require hospital admission in the future (censoring). As with all the other surviving fractions, the proportion of cases needing hospital care was estimated using Kaplan-Meier's method (Bogaerts et al., 2017; Ghani et al., 2005; Verity et al., 2020) . It is to be noted that the highest fraction occurs in the 60-69 group and the fraction is comparatively low for the 80+ group.

We used models to estimate parameters related to the progression of disease for This might be attributed to the difference in demographic structure. However, as our results also show, the times are only very slightly affected by age or sex.

The overall mean on both, hospitalization and ICU length, in our estimations differ from the data reported by the European Centre for Disease Prevention and Control (ECDP) in its report of April 8 (ECDC, 2020), which show for the UK an average stay of 4 days on ICU for survivors, and 5 days for non-survivors; in Colombia, we found 16.13 days of length in hospital and 8.63 days of stay in ICU. The same report presents a mean length of hospital stay of seven days for survivors and eight for non-survivors for the USA and China. In Colombia, those lengths are 24.5 days for survivors and 7.04

for non-survivors.

The ECDP reports a mean rate of hospitalization of 32% for the European community, and 10.6% for the USA and China. Our results show a similar rate (9.46%).

The raw data, is slightly different with a reported rate of 7.87%; Spain reported a markedly variation with a 38.4% of hospitalization rate. Also, the ECDP show a 2.4% rate of transition from hospital to Intensive Care Unit, similar to RNVE data, 3.9%. The data observed in Colombia (14.25%) and the estimated rate (16.52%) are higher.

Our model estimated a death rate of 4.3%: more than twice the rate reported by Although our estimates only use publicly available data, which are constantly adjusted, this is the type of data that is usually available in the course of the epidemic.

In fact, one secondary objective of the study was to assess the possibility of estimating the main parameters of the epidemic dynamics using only officially available data. 

This study uses only official data published daily by the Colombian government.

Although private conversations with some of the people in charge of gathering the information were held to evaluate the accuracy of the data, no further verification was possible. According to some responsible personnel, some changes may be registered the day following occurrence of the event. One potential limitation of this analysis is due to the lack of information on the proportion of deaths that were diagnosed as covid-19

cases after death. Nevertheless, those patients diagnosed with COVID-19 after their death are already reported in the database; whether or not the test results were J o u r n a l P r e -p r o o f delayed, the information was eventually recorded. Furthermore, according to our data, only 3.6% of all dead did not receive any kind of hospital care. Therefore, the error associated to this source of uncertainty is bounded. This report delay, however, does not mean that the date of death, the only information we are using to estimate probabilities and durations, is inaccurately recorded, once it is recorded, only that it was recorded after the date of death. Once the test results are in, the database is updated.

The only likely effect is associated to a possible bias introduced by the test results pending, for patients who died, at the moment when the information was last accessed.

To reduce the effect of delayed test results, the analysis of death times and proportions was based only on the latest information available at the end of the time period. Since the dates of death are always recorded, we believe that this source of uncertainty has a limited effect on the estimation of time to death and its probability. Including in the numerator fewer deaths than the real number may underestimate the CFR; so the worst scenario in our case, is that our CFR may be lower than the true value. Other indicators obtained from our analysis are less likely to be biased by this limitation.

There exists a concern also about the accuracy of the patient's daily location.

Only 3.6% of COVID-19 deaths did not receive medical care at hospitals. This proportion is unlikely to bias our main estimates on CFR or time to death since the date of death is not related to the likelihood of being tested for the virus. We were unable to estimate the proportion of people that may have been misclassified regarding the site where they receive medical care -hospital or ICU. Therefore, we cannot rule out some degree of uncertainty in our estimates of times between onset of disease and ICU or hospital care. However, our estimates appear to be robust, with narrow confidence intervals. A large proportion of misclassified people with time values widely departing from those with correct data would be necessary to produce a large bias in our estimates J o u r n a l P r e -p r o o f Funding HD and FDH received partial funding from Universidad Nacional de Colombia.

GE received funding from an NSF Rapid Grant (DEB 2027718). LR and NC had no financial support.

This study does not use any personal information. Only publicly available information was utilized. Animals were not involved, therefore, no ethical approval was necessary.

Authors declare no conflicts of interest.

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper

Survival analysis with interval-censored data: A practical approach with examples in r, sas, and bugs

Advanced Bayesian multilevel modeling with the R package brms

Covid-colombia: Colombian government official covid-19 data website

Age-dependent effects in the transmission and control of COVID-19 epidemics

ECDC. Covid-19-Rapid-Risk-Assessment-Coronavirus-Disease-2019-Eighth-Update-8

Contact tracing during Phase I of the COVID-19 pandemic in the Province of

Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe

Methods for Estimating the Case Fatality Ratio for a Novel, Emerging Infectious Disease

Age-related differences in nasopharyngeal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) levels in patients with mild to moderate coronavirus disease

Infectivity, susceptibility, and risk factors associated with SARS-CoV-2 transmission under intensive contact tracing in

IHME COVID-19 health service utilization forecasting Team, Murray CJ. Forecasting COVID-19 impact on hospital bed-days, ICU-days, ventilator-days and deaths by US

INS: Instituto Nacional de Salud Colombia

Report of the who-china joint mission on coronavirus disease

Ensemble forecasts of coronavirus disease

R: A language and environment for statistical computing

Estimating the burden of SARS-COV-2 in France

The contribution of the age distribution of cases to covid-19 case fatality across countries: A 9-country demographic study

Modeling survival data: Extending the Cox model

Estimates of the severity of coronavirus disease 2019: A model-based analysis. The Lancet Infectious Diseases

Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China

All data used in this work were prepared and made publicly available online by the Colombian National Institute of Health and the Ministry of Public Health.